T J Girard1, K Grunz1, N M Lasky1, J P Malone2, G J Broze1. 1. Division of Hematology, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA. 2. Proteomics Core Laboratory, Institute of Clinical and Translational Sciences, Washington University School of Medicine, St. Louis, MO, USA.
Abstract
Essentials Mouse models are often used to define roles of tissue factor pathway inhibitor (TFPI) in man. TFPI isoform-specific KOs reveal unexpected differences between mouse and human TFPI physiology. Mouse plasma contains 20 times more TFPI than man, derived from TFPIγ, a form not found in man. TFPIγ null mice, expressing only TFPI isoforms α and β, may better reflect the human situation. SUMMARY: Background Mouse models can provide insight into the pathophysiology of human thrombosis and hemostasis. Tissue factor pathway inhibitor (TFPI) regulates coagulation through protein S (PS)-enhanced factor (F) Xa inhibition and FXa-dependent inhibition of FVIIa/tissue factor (TF) activity. TFPI is expressed as isoforms α and β in man, and α, β and γ in the mouse. Objective Assess the reliability of extending TFPI-related studies in mice to humans. Method Compare mouse and human TFPI physiology using a variety of methods. Results Mouse TFPI and human TFPI are similar in regard to: (i) the mechanisms for FVIIa/TF and FXa inhibition; (ii) TFPIα is a soluble form and TFPIβ is glycosyl phosphatidyl inositol (GPI) membrane anchored; (iii) the predominant circulating form of TFPI in plasma is lipoprotein-associated; (iv) low levels of TFPIα circulate in plasma and increase following heparin treatment; and (v) TFPIα is the isoform in platelets. They differ in that: (i) mouse TFPI circulates at a ~20-fold higher concentration; (ii) mouse lines with isolated isoform deletions show this circulating mouse TFPI is derived from TFPIγ; (iii) sequences homologous to the mouse TFPIγ exon are present in many species, including man, but in primates are unfavorable for splicing; and (iv) tandem mass spectrometry (MS/MS) detects sequences for TFPI isoforms α and β in human plasma and α and γ in mouse plasma. Conclusion To dissect the pathophysiological roles of human TFPIα and TFPIβ, studies in TFPIγ null mice, expressing only α and β, only α or only β should better reflect the human situation.
Essentials Mouse models are often used to define roles of tissue factor pathway inhibitor (TFPI) in man. TFPI isoform-specific KOs reveal unexpected differences between mouse and humanTFPI physiology. Mouse plasma contains 20 times more TFPI than man, derived from TFPIγ, a form not found in man. TFPIγ null mice, expressing only TFPI isoforms α and β, may better reflect the human situation. SUMMARY: Background Mouse models can provide insight into the pathophysiology of humanthrombosis and hemostasis. Tissue factor pathway inhibitor (TFPI) regulates coagulation through protein S (PS)-enhanced factor (F) Xa inhibition and FXa-dependent inhibition of FVIIa/tissue factor (TF) activity. TFPI is expressed as isoforms α and β in man, and α, β and γ in the mouse. Objective Assess the reliability of extending TFPI-related studies in mice to humans. Method Compare mouse and humanTFPI physiology using a variety of methods. Results MouseTFPI and humanTFPI are similar in regard to: (i) the mechanisms for FVIIa/TF and FXa inhibition; (ii) TFPIα is a soluble form and TFPIβ is glycosyl phosphatidyl inositol (GPI) membrane anchored; (iii) the predominant circulating form of TFPI in plasma is lipoprotein-associated; (iv) low levels of TFPIα circulate in plasma and increase following heparin treatment; and (v) TFPIα is the isoform in platelets. They differ in that: (i) mouseTFPI circulates at a ~20-fold higher concentration; (ii) mouse lines with isolated isoform deletions show this circulating mouseTFPI is derived from TFPIγ; (iii) sequences homologous to the mouseTFPIγ exon are present in many species, including man, but in primates are unfavorable for splicing; and (iv) tandem mass spectrometry (MS/MS) detects sequences for TFPI isoforms α and β in human plasma and α and γ in mouse plasma. Conclusion To dissect the pathophysiological roles of humanTFPIα and TFPIβ, studies in TFPIγ null mice, expressing only α and β, only α or only β should better reflect the human situation.
Authors: Alan E Mast; Nayana Acharya; Mark J Malecha; Connie L Hall; Dennis J Dietzen Journal: Arterioscler Thromb Vasc Biol Date: 2002-12-01 Impact factor: 8.311
Authors: C Augustsson; A Svensson; B Kjaer; T-Y Chao; X Wenjuan; B O Krogh; J Breinholt; J T Clausen; I Hilden; H H Petersen; L C Petersen Journal: J Thromb Haemost Date: 2018-04-06 Impact factor: 5.824
Authors: Corina Rosales; Baiba K Gillard; Harry S Courtney; Francisco Blanco-Vaca; Henry J Pownall Journal: Biochemistry Date: 2009-08-25 Impact factor: 3.162
Authors: Nadine Müller-Calleja; Anne Hollerbach; Svenja Ritter; Denise G Pedrosa; Dennis Strand; Claudine Graf; Christoph Reinhardt; Susanne Strand; Philippe Poncelet; John H Griffin; Karl J Lackner; Wolfram Ruf Journal: Blood Date: 2019-08-21 Impact factor: 22.113
Authors: James T B Crawley; Argita Zalli; James H Monkman; Anastasis Petri; David A Lane; Josefin Ahnstrom; Isabelle I Salles-Crawley Journal: J Thromb Haemost Date: 2019-08-26 Impact factor: 5.824
Authors: Tanya T Marar; Nicholas D Martinez; Susan A Maroney; Amy E Siebert; Jie Wu; Timothy J Stalker; Maurizio Tomaiuolo; Sinny Delacroix; Robert D Simari; Alan E Mast; Lawrence F Brass Journal: J Thromb Haemost Date: 2021-07-14 Impact factor: 16.036